Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Bingham Kate, Director. Insider active across 1 company, notably BICYCLE THERAPEUTICS plc. Cumulatively, 2 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €33k. History available since 13 July 2021. The latest transaction was disclosed on 13 July 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Kate Bingham serves as a Director for Bicycle Therapeutics plc. She brings expertise in biotechnology and product development to the board. Her experience in the healthcare sector enables her to contribute to the company's strategy and guide key decisions.